HomeSLNO • NASDAQ
add
Soleno Therapeutics Inc
Previous close
$55.06
Day range
$55.30 - $56.50
Year range
$21.30 - $57.28
Market cap
2.17B USD
Avg Volume
729.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.23M | 179.55% |
Net income | -21.85M | -157.86% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -22.74M | -190.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 266.12M | 1,274.03% |
Total assets | 304.13M | 882.84% |
Total liabilities | 23.37M | 26.22% |
Total equity | 280.76M | — |
Shares outstanding | 38.87M | — |
Price to book | 7.53 | — |
Return on assets | -24.56% | — |
Return on capital | -27.34% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -21.85M | -157.86% |
Cash from operations | -17.65M | -217.12% |
Cash from investing | -120.92M | — |
Cash from financing | 152.75M | 795.36% |
Net change in cash | 14.18M | 23.34% |
Free cash flow | -10.96M | -335.86% |
About
Founded
1999
Headquarters
Website
Employees
33
